Dabigatran Etexilate Oxalate
Generic Name: dabigatran etexilate oxalate
Dosage form: POWDER. Active ingredients: DABIGATRAN ETEXILATE (1 kg/kg). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: DABIGATRAN ETEXILATE (1 kg/kg). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Arnica Montana, Bryonia Alba Root, Quinine Sulfate, Anamirta Cocculus Seed, Conium Maculatum Flowering Top, Strychnos Ignatii Seed, Ipecac, Potassium Carbonate, Strychnos Nux-vomica Seed, Sepia Officinalis Juice, Tobacco Leaf, Veratrum Album Root
arnica montana, bryonia alba root, quinine sulfate, anamirta cocculus seed, conium maculatum flowering top, strychnos ignatii seed, ipecac, potassium carbonate, strychnos nux-vomica seed, sepia officinalis juice, tobacco leaf, veratrum album root
Non-Standardized Plant Allergenic Extract [EPC]
USES: Temporarily relieves symptoms related to motion sickness.**
Ritonavir
ritonavir
Cytochrome P450 3A Inhibitor [EPC]
11 DESCRIPTION Ritonavir is an inhibitor of HIV protease with activity against the Human Immunodeficiency Virus (HIV). Ritonavir is chemically designated as 10-Hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid, 5-thiazolylmethyl ester, [5S-(5R*,8R*,10R*,11R*)]. Its molecular formula is C 37 H 48 N 6 O 5 S 2 , and its molecular weight is 720.95.
Evolocumab
evolocumab
PCSK9 Inhibitor [EPC]
11 DESCRIPTION Evolocumab is a human monoclonal immunoglobulin G2 (IgG2) directed against human proprotein convertase subtilisin kexin type 9 (PCSK9). Evolocumab has an approximate molecular weight (MW) of 144 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells. REPATHA is a sterile, preservative-free, clear to opalescent, colorless to pale yellow solution for subcutaneous use.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.